Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma

Volume: 5, Issue: 1
Published: Jun 29, 2021
Abstract
Pancreatic ductal adenocarcinoma (PDAC), characterized by dense desmoplastic stroma laid down by pancreatic stellate cells (PSC), has no reliable diagnostic biomarkers for timely detection. A multi-center cohort of PDAC patients and controls (chronic pancreatitis, intra-ductal papillary neoplasms, gallstones and otherwise healthy) donated serum in an ethically approved manner. Serum PTX3 above 4.34 ng/mL has a higher sensitivity (86%, 95%...
Paper Details
Title
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
Published Date
Jun 29, 2021
Volume
5
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.